Correlation Between Transcode Therapeutics and Heartbeam

Can any of the company-specific risk be diversified away by investing in both Transcode Therapeutics and Heartbeam at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transcode Therapeutics and Heartbeam into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Transcode Therapeutics and Heartbeam, you can compare the effects of market volatilities on Transcode Therapeutics and Heartbeam and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transcode Therapeutics with a short position of Heartbeam. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transcode Therapeutics and Heartbeam.

Diversification Opportunities for Transcode Therapeutics and Heartbeam

0.09

Correlation Coefficient

Transcode Therapeutics  Heartbeam

Significant diversification

The 3 months correlation between Transcode and Heartbeam is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Transcode Therapeutics and Heartbeam in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heartbeam and Transcode Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transcode Therapeutics are associated (or correlated) with Heartbeam. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heartbeam has no effect on the direction of Transcode Therapeutics i.e., Transcode Therapeutics and Heartbeam go up and down completely randomly.

Pair Corralation between Transcode Therapeutics and Heartbeam

Given the investment horizon of 90 days Transcode Therapeutics is expected to generate 2.06 times more return on investment than Heartbeam. However, Transcode Therapeutics is 2.06 times more volatile than Heartbeam. It trades about -0.02 of its potential returns per unit of risk. Heartbeam is currently generating about -0.14 per unit of risk. If you would invest  1,579  in Transcode Therapeutics on May 1, 2025 and sell it today you would lose (403.00) from holding Transcode Therapeutics or give up 25.52% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Transcode Therapeutics  vs.  Heartbeam

Transcode Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Transcode Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Heartbeam

Risk-Adjusted Performance

Very Weak

Over the last 90 days Heartbeam has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in August 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Transcode Therapeutics and Heartbeam

The main advantage of trading using opposite Transcode Therapeutics and Heartbeam positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transcode Therapeutics position performs unexpectedly, Heartbeam can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heartbeam will offset losses from the drop in Heartbeam's long position.

The idea behind Transcode Therapeutics and Heartbeam pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.